Wednesday, November 29, 2023 11:26:01 AM
Revenge (following a bad experience with Leon)? Support for your own accumulation of shares? Being paid to do your posting? Frustration after you lost big with this stock in the past? ...
Whatever the case, with minimum honesty you would admit that there is an operating company behind the stock, it generates revenues, it duly report quaterly and this RISKY BET is justifyable up to a point.
At current pps (+ o - $500 per million shares) there is not much to lose but, if Leon succeed at whatever he is trying to do to rebuilt this company (find large investors, obtain government grants, ...) the upward potential is to say the least quite interesting. (current multiplier behind our current pps is more or less 0.3).
You can believe that this business is a total failure in the making but if you can be honest you should also believe that Leon is trying to succeed and not a scammer.
In the stock market one can INVEST or BET.
GRST is currently a BET and you, pretending to do serious analysis of it as if it was an INVESTMENT proves you to be ridiculous or even worse.
I for one have a bet on the table and look forward to the next cards to be turned.
Patiently,
Roger
Recent GRST News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 09:45:09 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2023 09:54:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/22/2023 09:04:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:55:26 PM
- Form 1-A POS - • Edgar (US Regulatory) • 10/20/2023 07:29:40 PM
- Form 1-A POS - • Edgar (US Regulatory) • 08/29/2023 07:21:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:37:36 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 12:43:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 04:51:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2023 06:56:41 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM